Juraj Payer

Prof. Dr. Juraj Payer


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
YJYashar Jalali
Yashar Jalali
AKAndrea Kološová
Andrea Kološová
KDKarol Džupa
Karol Džupa
PPPavol Pavlovič
Pavol Pavlovič
MJMonika Jalali
Monika Jalali
JPJuraj Payer
Juraj Payer
Background/Objectives: In healthcare environments with high microbial loads, effective infection control measures are critical for reducing airborne and surface contamination. One of the novel modalities in the achievement of these goals is the use of antimicrobial mists, such as droplets, in the form of dry fog. Although the usage of dry fog in the disinfection of contained healthcare microenvironments is well known, the effect of such a system in terms of a meaningful reduction in the microbial burden in an open inpatient ward is unclear. Our objective was to assess the impact of scheduled dry fogging on microbial reduction in such settings. Methods: We collected air and surface samples from rooms receiving daily, biweekly, or no fogging (controls) over six months, establishing the baseline contamination and evaluating the reduction trends in treated rooms. The “reduction effect” was measured by tracking microbial isolation trends before and after treatment, while the “degree of reduction” assessed differences across rooms with varied disinfection schedules. Results: The results indicate that scheduled dry fogging significantly reduced microbial loads in treated rooms, especially with daily disinfection (SE = 64.484, p = 0.002). The airborne contamination in treated rooms showed a strong downward trend over time (SE = 19.192, p < 0.001). Surface contamination remained challenging due to frequent recontamination; however, treated rooms exhibited a consistent reduction in microbial presence (SE = 2.002, p = 0.010), confirming dry fogging’s role as a valuable adjunct to routine cleaning. Conclusions: In conclusion, this study highlights that dry fogging effectively reduces microbial loads in open, high-traffic healthcare environments, supporting its use as part of a multimodal infection control strategy.

4 September 2024 in Vnitrni Lekarstvi
Verified
Journal Article
Open access
PDF file
JPJuraj Payer
Juraj Payer
PJPeter Jackuliak
Peter Jackuliak
PVPeter Vaňuga
Peter Vaňuga
MKMartin Kužma
Martin Kužma
V tomto ?l?nku sa venujeme endokrinne sprostredkovanej osteopor?ze sp?sobenej poruchami sekr?cie rastov?ho horm?nu (RH); nedostatku rastov?ho horm?nu u dospel?ch a akromeg?lii. RH a inzul?nu podobn? rastov? faktor-1 (IGF-1) stimuluj? line?rny ... V tomto ?l?nku sa venujeme endokrinne sprostredkovanej osteopor?ze sp?sobenej poruchami sekr?cie rastov?ho horm?nu (RH); nedostatku rastov?ho horm?nu u dospel?ch a akromeg?lii. RH a inzul?nu podobn? rastov? faktor-1 (IGF-1) stimuluj? line?rny ...

11 November 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YJYashar Jalali
Yashar Jalali
AKAndrea Kološová
Andrea Kološová
Adriána LiptákováAdriána Liptáková
Adriána Liptáková
JKJan Kyselovic
Jan Kyselovic
AOAnna Oleárová
Anna Oleárová
JPJuraj Payer
Juraj Payer
Background/Objectives: Over the past few decades, extended-spectrum β-lactamase (ESBL)-producing bacteria have become a great concern in healthcare systems worldwide, imposing large burdens by increasing antimicrobial resistance and patient morbidity. Given the high mortality rates and emergence of multidrug-resistant (MDR) strains, monitoring ESBL prevalence and resistance patterns is crucial. This study aimed to evaluate ESBL-producing Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae over three years, focusing on phenotypic distribution and resistance profiles. Methods: A total of 1599 ESBL-producing bacterial samples were collected and analysed. A panel of 20 antibiotics was tested to determine resistance traits. Data were recorded on phenotypical distribution, isolation types, changes in antibiotic resistance, and the relation of such changes to antibiotic consumption (defined daily dose) from clinical isolates. Results: Phenotypical analysis revealed the minimal presence of the Cefotaximase from Munich (CTX-M) phenotype in E. coli and K. pneumoniae, creating a distinct epidemiological profile compared to global patterns. Shifts in isolation trends, particularly in P. mirabilis, suggest an expected increase in associated-mortality-rate in the coming years. While resistance trends were not statistically significant, MDR and extensively drug-resistant (XDR) strains were identified across all three bacteria. Only meropenem showed consistent 100% efficacy against E. coli, with other antibiotics displaying only partial effectiveness. Conclusions: These findings highlight the need for ongoing surveillance of ESBL-producing bacteria and underscore challenges in managing antibiotic resistance due to limited efficacy of last-resort treatments. The unique phenotypical distribution observed could impact local resistance management strategies in hospital settings in the coming years.

30 October 2025 in Bratislava Medical Journal
Verified
Journal Article
Open access
PDF file
KMK. Mikušková
K. Mikušková
DHD. Hvizdoš
D. Hvizdoš
DSD. Statelová
D. Statelová
JPJuraj Payer
Juraj Payer
TSTomáš Siebert
Tomáš Siebert
Medication-related osteonecrosis of the jaw (MRONJ) is a rare but severe complication of antiresorptive therapy with bisphosphonates or denosumab in osteoporotic patients. MRONJ can adversely affect both quality of life and the treatment of osteoporosis. The aim of this study was to evaluate the efficacy of early surgical treatment of MRONJ lesions and to assess the possible influence of variables such as advanced age, advanced stage of MRONJ, and concomitant treatment of rheumatoid arthritis on treatment outcomes. We performed a retrospective evaluation of osteoporotic patients treated for stage I-III MRONJ at a single institution between January 2016 and December 2022. All patients underwent early surgical treatment according to a standardized therapeutic protocol and were followed up for at least 6 months after surgical treatment. Eighty-eight patients, mostly women (95.5%), were surgically treated for 93 MRONJ stage I (9.8%), II (73.1%), and III (17.2%) lesions. Thirteen patients (14.8%) were concurrently treated for rheumatoid arthritis. Early surgical treatment resulted in complete cure of MRONJ lesions with a single surgical procedure in 86 of 88 patients (97.7%) and 91 of 93 MRONJ lesions (97.8%). Age over 75 years, advanced-stage MRONJ and concomitant treatment for rheumatoid arthritis were not negatively associated with surgical treatment outcomes in this study. Early surgical treatment according to the described treatment protocol is highly effective in achieving complete healing of MRONJ lesions in osteoporotic patients regardless of disease stage and can be used as a first-line treatment in patients with osteoporosis who have no contraindications and consent to surgical treatment.

26 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Ludmila OreskaLudmila Oreska
Ludmila Oreska
BKBarbora Kundeková
Barbora Kundeková
LVLukáš Varga
Lukáš Varga
Katarína StebelováKatarína Stebelová
Katarína Stebelová
MOMonika Okuliarova
Monika Okuliarova
MSMilan Sedliak
Milan Sedliak
Endurance performance is influenced by age- and sex-specific physiological determinants, while emerging evidence indicates an increasing prevalence of Relative Energy Deficiency in Sport (REDs) among both young and master endurance runners. Despite its clinical relevance, limited data exist on how long-term endurance training modulates REDs risk, skeletal muscle characteristics, and physiological ageing in comparison with inactive individuals. Methods: This cross-sectional study protocol will examine 112 participants stratified by sex, age (20–35 vs. 65–80 years), and training status (endurance runners vs. inactive controls). Cardiorespiratory fitness (VO₂max) is defined as the primary outcome. Secondary outcomes include body composition, musculoskeletal function, biochemical and hormonal markers, and REDs–related screening variables. Assessments will comprise cardiorespiratory testing, DXA-based bone and body composition analysis, isometric knee dynamometry, mobility testing, validated REDs screening tools (LEAF-Q, LEAM-Q, and IOC REDs CAT2), seven-day dietary and training monitoring, venous blood sampling, and skeletal muscle biopsies from the vastus lateralis. Results: The study is designed to generate an integrated overview of physiological, nutritional, metabolic, and muscle-cell characteristics across sex-, age-, and training-specific subgroups. Conclusions: This protocol provides comprehensive insight into how ageing and sex influence endurance physiology and REDs susceptibility, and whether long-term endurance training preserves functional capacity across the lifespan. The findings aim to support evidence-based screening, prevention, and targeted interventions for REDs in endurance athletes.

19 March 2026 in Sports
Verified
Journal Article
Open access
PDF file
Ludmila OreskaLudmila Oreska
Ludmila Oreska
BKBarbora Kundeková
Barbora Kundeková
LVLukáš Varga
Lukáš Varga
Katarína StebelováKatarína Stebelová
Katarína Stebelová
MOMonika Okuliarova
Monika Okuliarova
MSMilan Sedliak
Milan Sedliak
Endurance performance is influenced by age- and sex-specific physiological determinants, while emerging evidence indicates an increasing prevalence of Relative Energy Deficiency in Sport (REDs) among both young and master endurance runners. Despite its clinical relevance, limited data exist on how long-term endurance training modulates REDs risk, skeletal muscle characteristics, and physiological ageing in comparison with inactive individuals. Methods: This cross-sectional study protocol will examine 112 participants stratified by sex, age (20–35 vs. 65–80 years), and training status (endurance runners vs. inactive controls). Cardiorespiratory fitness (VO2max) is defined as the primary outcome. Secondary outcomes include body composition, musculoskeletal function, biochemical and hormonal markers, and REDs-related screening variables. Assessments will comprise cardiorespiratory testing, DXA-based bone and body composition analysis, isometric knee dynamometry, mobility testing, validated REDs screening tools (LEAF-Q, LEAM-Q, and IOC REDs CAT2), seven-day dietary and training monitoring, venous blood sampling, and skeletal muscle biopsies from the vastus lateralis. Results: This study is designed to generate an integrated overview of physiological, nutritional, metabolic, and muscle-cell characteristics across sex-, age-, and training-specific subgroups. Conclusions: This protocol provides comprehensive insight into how ageing and sex influence endurance physiology and REDs susceptibility and whether long-term endurance training preserves functional capacity across the lifespan. The findings aim to support evidence-based screening, prevention, and targeted interventions for REDs in endurance athletes.